Loading clinical trials...
Loading clinical trials...
TAK-676 Alone and in Combination(s) With Carboplatin, 5-Fluorouracil, and Paclitaxel in Patients With Head and Neck Squamous Cell Carcinoma
Conditions
Interventions
TAK-676
Carboplatin
+7 more
Locations
4
United States
LSU Health Sciences Center - Shreveport
Shreveport, Louisiana, United States
Montefiore Medical Center
The Bronx, New York, United States
University of Cincinnati Health
Cincinnati, Ohio, United States
University of Pennsylvania
Philadelphia, Pennsylvania, United States
Start Date
July 26, 2021
Primary Completion Date
November 15, 2022
Completion Date
November 15, 2022
Last Updated
October 6, 2023
NCT06980038
NCT05039801
NCT06806852
NCT05526924
NCT05977907
NCT02734537
Lead Sponsor
Presage Biosciences
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions